Physician profile
Barbara Laird
NPI 1518397959
$1,231.72
in general payments reported to CMS, 2019-2025
14 companies · $532 in 2025
The $532 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $687 · 2024: $13.33 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $545.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $289.49 | 2021 | |
| Janssen Pharmaceuticals, INC | $216.37 | 2025 | Invega Sustenna, Invega Trinza |
| Lundbeck LLC | $114.47 | 2021-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $111.95 | 2021 | |
| Abbvie INC. | $110.41 | 2021-2024 | |
| Neurocrine Biosciences, INC. | $97.31 | 2025 | |
| Supernus Pharmaceuticals, INC. | $68.80 | 2021 | |
| Bausch Health US, LLC | $63.30 | 2025 | Aplenzin |
| Collegium Pharmaceutical, INC. | $49.86 | 2025 | Jornay Pm |
| Vanda Pharmaceuticals INC. | $36.27 | 2025 | Fanapt |
| Almatica Pharma LLC | $23.71 | 2025 | Loreev Xr |
| Otsuka America Pharmaceutical, INC. | $20.58 | 2021 | |
| Corium, LLC | $16.58 | 2025 | Azstarys |
| Jazz Pharmaceuticals INC. | $12.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Laird listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.